UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

New Perspectives in Dried Blood Spot Biomarkers for Lysosomal Storage Diseases

Spiewak, Justyna; Doykov, Ivan; Papandreou, Apostolos; Hällqvist, Jenny; Mills, Philippa; Clayton, Peter T; Gissen, Paul; ... Heywood, Wendy E; + view all (2023) New Perspectives in Dried Blood Spot Biomarkers for Lysosomal Storage Diseases. International Journal of Molecular Sciences , 24 (12) , Article 10177. 10.3390/ijms241210177. Green open access

[thumbnail of ijms-24-10177.pdf]
Preview
PDF
ijms-24-10177.pdf - Published Version

Download (1MB) | Preview

Abstract

Dried blood spots (DBSs) biomarkers are convenient for monitoring for specific lysosomal storage diseases (LSDs), but they could have relevance for other LSDs. To determine the specificity and utility of glycosphingolipidoses biomarkers against other LSDs, we applied a multiplexed lipid liquid chromatography tandem mass spectrometry assay to a DBS cohort of healthy controls (n = 10) and Gaucher (n = 4), Fabry (n = 10), Pompe (n = 2), mucopolysaccharidosis types I–VI (n = 52), and Niemann–Pick disease type C (NPC) (n = 5) patients. We observed no complete disease specificity for any of the markers tested. However, comparison among the different LSDs highlighted new applications and perspectives of the existing biomarkers. We observed elevations in glucosylceramide isoforms in the NPC and Gaucher patients relative to the controls. In NPC, there was a greater proportion of C24 isoforms, giving a specificity of 96–97% for NPC, higher than 92% for the NPC biomarker N-palmitoyl-O-phosphocholineserine ratio to lyso-sphingomyelin. We also observed significantly elevated levels of lyso-dihexosylceramide in Gaucher and Fabry disease as well as elevated lyso-globotriaosylceramide (Lyso-Gb3) in Gaucher disease and the neuronopathic forms of Mucopolysaccharidoses. In conclusion, DBS glucosylceramide isoform profiling has increased the specificity for the detection of NPC, thereby improving diagnostic accuracy. Low levels of lyso-lipids can be observed in other LSDs, which may have implications in their disease pathogenesis.

Type: Article
Title: New Perspectives in Dried Blood Spot Biomarkers for Lysosomal Storage Diseases
Open access status: An open access version is available from UCL Discovery
DOI: 10.3390/ijms241210177
Publisher version: https://doi.org/10.3390/ijms241210177
Language: English
Additional information: This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third-party material in this article are included in the Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
Keywords: Fabry disease; glycosphingolipid; biomarker; Gaucher disease; mucopolysaccharidoses; Niemann–Pick C disease; dried blood spot
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health > Genetics and Genomic Medicine Dept
URI: https://discovery.ucl.ac.uk/id/eprint/10172586
Downloads since deposit
23Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item